MedMira Inc. (TSXV:MIR)
Canada · Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
Sep 18, 2026, 9:30 AM EST
MedMira Market Cap
MedMira has a market cap or net worth of CAD 45.61 million as of September 18, 2026. Its market cap has decreased by -18.75% in one year.
Market Cap
45.61M
Enterprise Value
63.03M
Revenue
370.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since June 30, 2000, MedMira's market cap has decreased from 81.66M to 45.61M, a decrease of -44.14%. That is a compound annual growth rate of -2.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 45.61M | - |
| Dec 31, 2025 | 45.61M | -31.58% |
| Dec 31, 2024 | 66.66M | -13.11% |
| Dec 29, 2023 | 76.72M | 37.50% |
| Dec 30, 2022 | 55.80M | -60.00% |
| Dec 31, 2021 | 139.49M | -13.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 57.84M |
| ME Therapeutics Holdings | 53.18M |
| BriaCell Therapeutics | 51.42M |
| Sona Nanotech | 43.59M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 41.09M |
| Sernova Biotherapeutics | 39.65M |
| Medicenna Therapeutics | 39.23M |